https://www.cannenta.com/cannenta-has-signed-a-heads-of-agreement-with-nexgel-inc/2023-05-29T09:10:07+10:00https://www.cannenta.com/cannenta-has-signed-a-heads-of-agreement-with-tianjin-medis/2023-05-29T09:17:59+10:00https://www.cannenta.com/cannenta-announces-first-patients-in-human-trials-of-their-unique-pro-angiogenic-wound-treatment/2025-05-02T00:17:46+10:00